drugset / Trial / NCT00493246

Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric Inpatients

NCT00493246

Phase 1 Completed 75 enrolled Mallinckrodt
RandomizedSingle-groupOpen-labelTreatment

Summary

We are doing this study to find out what happens to acetaminophen in the body after it is given to children through the vein. Children's bodies may handle drugs differently than adults. Understanding how long the drug stays in the body and how the drug is changed or metabolized by the body (called pharmacokinetics) is an important step in learning what the best dose of acetaminophen for children should be. We are also interested in learning about the safety of this medication when given to children.

Timeline

Start
2007-06
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 12.5 mg/kg Intravenous
Subject Acetaminophen Small molecule 15 mg/kg Intravenous

Indications

No indication recorded.